Multichannel Vestibular Implant Early Feasibility Study

Status Active, not recruiting

Clinical Trial Summary

Although cochlear implants can restore hearing to individuals who have lost cochlear hair cell function, there is no adequately effective treatment for individuals suffering chronic imbalance, postural instability and unsteady vision due to loss of vestibular hair cell function. Preclinical studies have demonstrated that electrical stimulation of the vestibular nerve via a chronically implanted multichannel vestibular prosthesis can partially restore vestibular reflexes that maintain steady posture and vision. This pilot clinical feasibility study of a multichannel vestibular implant system will evaluate this approach in up to ten human subjects with bilateral vestibular deficiency due to gentamicin ototoxicity or other causes of inner ear dysfunction.

Clinical Trial Description

The system used in this study is the (MVI)™ Multichannel Vestibular Implant System produced by Labyrinth Devices, LLC. It is similar to commercially available cochlear implants in that it includes an implanted stimulator powered and controlled by an external unit, which communicate with the implant across the skin via an inductive link. Unlike a cochlear implant, the implanted stimulator's electrode array is designed for implantation near the ends of the vestibular nerve. The implanted stimulator also includes additional magnets to help facilitate retention of the external unit on the scalp over the implant. The external unit includes a head-worn unit (for sensing head motion and delivering power and signals to the implanted stimulator) and a power and control unit containing a battery and microprocessor. Participants in this trial who meet candidacy criteria and who choose to proceed with implantation surgery, device activation and device deactivation will be asked to participate in a series of post-operative monitoring visits over a ≥1 year period. ;

Study Design

Related Conditions & MeSH terms

Bilateral Vestibular Deficiency (BVD)
Bilateral Vestibulopathy
Gentamicin Ototoxicity
Labyrinth Diseases
Labyrinthitis
Other Disorders of Vestibular Function, Bilateral
Ototoxicity
Sensation Disorders
Vestibular Diseases

Clinical Trial Details

NCT number	NCT02725463
Study type	Interventional
Source	Johns Hopkins University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	April 2016
Completion date	March 31, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02533739` - Vestibular Disorder and Visuo-spatial Functions	N/A
Completed	`NCT00271791` - Prednisone Treatment for Vestibular Neuronitis	Phase 2
Recruiting	`NCT06332326` - Investigation of the Efficacy of Non-Invasive Vagus Nerve Stimulation and Physiotherapy in Unilateral Vestibular Hypofunction Patients	N/A
Completed	`NCT01483937` - Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium	N/A
Recruiting	`NCT05634902` - Implementation of Evidence-Based Practice for Dizziness	N/A
Recruiting	`NCT05436067` - Individualized Vestibular Rehabilitation for Elderly With Self-Management and Gaming Elements	N/A
Completed	`NCT02753179` - Covert-saccades, Dynamic Visual Acuity and Quality of Life	N/A
Completed	`NCT03160352` - Effects of Exergames on Vestibular Function in Healthy Community Dwellers.	N/A
Completed	`NCT03887923` - Vestibular Physical Therapy for People With Alzheimer Disease	N/A
Terminated	`NCT01305278` - The Efficacy of Balance Gaming as an Adjunct to Vestibular Rehabilitation Therapy	N/A
Completed	`NCT03464214` - The Effects of Local Vibration and Cervical Stabilization Exercises Applied on Neck Muscles on Balance in Healthy Individuals	N/A
Recruiting	`NCT03799991` - Vestibular Therapy in Alzheimer's Disease	N/A
Completed	`NCT02722486` - Use of a Vibrotactile Balance Belt System for Vestibular Rehabilitation in the Pediatric Population	N/A
Not yet recruiting	`NCT06350669` - App-supported Vestibular Rehabilitation (RCT)	N/A
Recruiting	`NCT03716908` - Genotype-phenotype Correlation Study of Presymptomatic and Symptomatic DFNA9 Patients
Completed	`NCT00768378` - Safety and Efficacy Study of BrainPort® Balance Device in Peripheral Vestibular Dysfunction.	N/A
Withdrawn	`NCT03578354` - 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine	Phase 2
Completed	`NCT00702832` - Effect of Vestibular Rehabilitation - a Randomized Controlled Trial	N/A
Recruiting	`NCT00146952` - Use of a Vibrotactile Sensory Prosthesis in Patients With Postural Imbalance and Spatial Disorientation	Phase 1
Recruiting	`NCT05674786` - Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.